Pharmacophore model for biased agonists of angiotensin II receptor type 1: a molecular modeling study (2014)
- Authors:
- USP affiliated authors: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; YAGUI, CARLOTA DE OLIVEIRA RANGEL - FCF
- Unidade: FCF
- Subjects: MODELAGEM MOLECULAR; ANGIOTENSINA II
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 50, suppl. 1, p. 11 res. FCF017, 2014
- Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences
-
ABNT
MODESTIA, Silvestre Massimo et al. Pharmacophore model for biased agonists of angiotensin II receptor type 1: a molecular modeling study. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 dez. 2025. , 2014 -
APA
Modestia, S. M., Sá, M. M. de, Trossini, G. H. G., & Rangel-Yagui, C. de O. (2014). Pharmacophore model for biased agonists of angiotensin II receptor type 1: a molecular modeling study. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Modestia SM, Sá MM de, Trossini GHG, Rangel-Yagui C de O. Pharmacophore model for biased agonists of angiotensin II receptor type 1: a molecular modeling study. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 11 res. FCF017.[citado 2025 dez. 03 ] -
Vancouver
Modestia SM, Sá MM de, Trossini GHG, Rangel-Yagui C de O. Pharmacophore model for biased agonists of angiotensin II receptor type 1: a molecular modeling study. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 11 res. FCF017.[citado 2025 dez. 03 ] - Convergent QSAR studies on a series of NK3 receptor antagonists for schizophrenia treatment
- Comparison between full and biased agonist's interactions with the angiotensin II type 1 receptor
- Comparison between full and biased agonist's interactions with the angiotensin II type 1 receptor
- Biased agonist TRV027 determinants in AT1R by molecular dynamics simulations
- In silico study of the binding mode of biased agonists of the angiotensin II type 1 receptor (AT1)
- Synthesis of inhibitors of sirtuin 2 for chagas disease
- Synthesis, molecular modeling and docking studies of nitrofurazone analogues as trypanomicine candidates
- Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides
- Building and validation of a pharmacophore model of LSD-1 inhibitors for virtual screening
- Quantitative structure-activity relationships (HQSAR, CoMFA and CoMSIA) studies for a COX-2 selective inhibitors
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
